Phase 2 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 80 years old
- People who have had a complete peripheral nerve injury in the arm caused by trauma, and who arrive for treatment within 48 hours of the injury
- People whose injury affects movement and/or feeling in one of these specific arm nerves: the axillary, radial, median, ulnar, or musculocutaneous nerve, and where the injury is located between the upper arm bone (humerus) and the wrist crease
- People whose injured nerve, at the location of the injury, would normally carry both movement and sensation signals (confirm with trial site)
Who may not be able to join:
- People who need surgery within just a few hours of the injury, before trial processes can begin
- People whose nerve injury involves the brachial plexus (the network of nerves closer to the neck and shoulder)
- People whose nerve injury is below the wrist crease
- People whose injury only involves a nerve branch that carries sensation only, or certain specific nerve branches in the forearm beyond their midpoint (confirm with trial site for specific nerve names)
- People who have had a previous peripheral nerve injury, or who have a history of stroke, or a muscle, nerve, or neuromuscular condition
- People who have a documented psychiatric condition that is considered likely to result in self-harm or make it difficult to attend follow-up appointments
- People who are likely to have serious difficulties attending follow-up visits, such as those who are in prison or experiencing homelessness at the time of injury, or those with intellectual challenges without adequate family support
- People who are not expected to survive the next 30 days due to their injuries or health condition
- People who have a known allergy to polyethylene glycol (PEG)
- People where certain baseline assessments cannot be completed on the uninjured arm, or where sensation testing on the uninjured arm shows results above a specific threshold during the baseline assessment (confirm with trial site)
- People who are pregnant or breastfeeding
- People who have a significant other health condition that would prevent immediate surgical repair of the nerve
- People who are unable to closely follow all requirements of the clinical trial protocol
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ala Elhelali, PhD, Johns Hopkins University
Phone: 410-955-0396
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complications or problems that occur with in the first 30 days.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.